Gilead agrees on affordable medicines plan with US government
The company recently announced a $32bn investment in US R&D and manufacturing
Read More
Section: Healthcare
Novartis agrees to lower drug prices in deal with US government
In 2025, the pharma company announced a $23bn US investment commitment
Read More
Merck announces agreement with US government to reduce prices of prescription medication
The pharma company will invest more than $70bn in the US to boost production and innovation
Read More
Predicting the future of health equity in the pharmaceutical industry
By Natalia Barkalina and Noah Froud
Read More
The trust crisis: how pharma must evolve to engage Gen Z HCPs
Trust isn’t a campaign outcome; it’s the product of behaviour, language and consistency
Read More